
Global Eubiotics Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
Description
Summary
According to APO Research, The global Eubiotics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Eubiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Eubiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Eubiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Eubiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Eubiotics include YARA International Asa, SCC Holdings Berhad, Royal DSM, Kemin Industries, DuPont, Chr. Hansen A/S, Cargill Incorporated, Beneo Group and Behn Meyer Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Eubiotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Eubiotics, also provides the sales of main regions and countries. Of the upcoming market potential for Eubiotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Eubiotics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Eubiotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Eubiotics sales, projected growth trends, production technology, application and end-user industry.
Eubiotics Segment by Company
YARA International Asa
SCC Holdings Berhad
Royal DSM
Kemin Industries
DuPont
Chr. Hansen A/S
Cargill Incorporated
Beneo Group
Behn Meyer Group
BASF SE
Eubiotics Segment by Type
Probiotics
Organic Acid
Eubiotics Segment by Application
Animals
Application 2
Eubiotics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eubiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Eubiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eubiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Eubiotics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Eubiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Eubiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Eubiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Eubiotics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Eubiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Eubiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Eubiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Eubiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Eubiotics include YARA International Asa, SCC Holdings Berhad, Royal DSM, Kemin Industries, DuPont, Chr. Hansen A/S, Cargill Incorporated, Beneo Group and Behn Meyer Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Eubiotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Eubiotics, also provides the sales of main regions and countries. Of the upcoming market potential for Eubiotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Eubiotics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Eubiotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Eubiotics sales, projected growth trends, production technology, application and end-user industry.
Eubiotics Segment by Company
YARA International Asa
SCC Holdings Berhad
Royal DSM
Kemin Industries
DuPont
Chr. Hansen A/S
Cargill Incorporated
Beneo Group
Behn Meyer Group
BASF SE
Eubiotics Segment by Type
Probiotics
Organic Acid
Eubiotics Segment by Application
Animals
Application 2
Eubiotics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eubiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Eubiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eubiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Eubiotics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Eubiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Eubiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Eubiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
196 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Eubiotics Market Size, 2020 VS 2024 VS 2031
- 1.3 Global Eubiotics Market Size Estimates and Forecasts (2020-2031)
- 1.4 Global Eubiotics Sales Estimates and Forecasts (2020-2031)
- 1.5 Global Eubiotics Market Average Price (2020-2031)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 2 Global Eubiotics Market Dynamics
- 2.1 Eubiotics Industry Trends
- 2.2 Eubiotics Industry Drivers
- 2.3 Eubiotics Industry Opportunities and Challenges
- 2.4 Eubiotics Industry Restraints
- 3 Eubiotics Market by Manufacturers
- 3.1 Global Eubiotics Revenue by Manufacturers (2020-2025)
- 3.2 Global Eubiotics Sales by Manufacturers (2020-2025)
- 3.3 Global Eubiotics Average Sales Price by Manufacturers (2020-2025)
- 3.4 Global Eubiotics Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Eubiotics Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Eubiotics Manufacturers, Product Type & Application
- 3.7 Global Eubiotics Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Eubiotics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Eubiotics Players Market Share by Revenue in 2024
- 3.8.3 2024 Eubiotics Tier 1, Tier 2, and Tier 3
- 4 Eubiotics Market by Type
- 4.1 Eubiotics Type Introduction
- 4.1.1 Probiotics
- 4.1.2 Organic Acid
- 4.2 Global Eubiotics Sales by Type
- 4.2.1 Global Eubiotics Sales by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Eubiotics Sales by Type (2020-2031)
- 4.2.3 Global Eubiotics Sales Market Share by Type (2020-2031)
- 4.3 Global Eubiotics Revenue by Type
- 4.3.1 Global Eubiotics Revenue by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Eubiotics Revenue by Type (2020-2031)
- 4.3.3 Global Eubiotics Revenue Market Share by Type (2020-2031)
- 5 Eubiotics Market by Application
- 5.1 Eubiotics Application Introduction
- 5.1.1 Animals
- 5.1.2 Application 2
- 5.2 Global Eubiotics Sales by Application
- 5.2.1 Global Eubiotics Sales by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Eubiotics Sales by Application (2020-2031)
- 5.2.3 Global Eubiotics Sales Market Share by Application (2020-2031)
- 5.3 Global Eubiotics Revenue by Application
- 5.3.1 Global Eubiotics Revenue by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Eubiotics Revenue by Application (2020-2031)
- 5.3.3 Global Eubiotics Revenue Market Share by Application (2020-2031)
- 6 Global Eubiotics Sales by Region
- 6.1 Global Eubiotics Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Eubiotics Sales by Region (2020-2031)
- 6.2.1 Global Eubiotics Sales by Region (2020-2025)
- 6.2.2 Global Eubiotics Sales Forecasted by Region (2025-2030)
- 6.3 North America
- 6.3.1 North America Eubiotics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.3.2 North America Eubiotics Sales by Country (2020-2031)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Eubiotics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.4.2 Europe Eubiotics Sales by Country (2020-2031)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Eubiotics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.5.2 Asia Pacific Eubiotics Sales by Country (2020-2031)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Eubiotics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.6.2 South America, Middle East and Africa Eubiotics Sales by Country (2020-2031)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
- 7 Global Eubiotics Revenue by Region
- 7.1 Global Eubiotics Revenue by Region
- 7.1.1 Global Eubiotics Revenue by Region: 2020 VS 2024 VS 2031
- 7.1.2 Global Eubiotics Revenue by Region (2020-2025)
- 7.1.3 Global Eubiotics Revenue by Region (2026-2031)
- 7.1.4 Global Eubiotics Revenue Market Share by Region (2020-2031)
- 7.2 North America
- 7.2.1 North America Eubiotics Revenue (2020-2031)
- 7.2.2 North America Eubiotics Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.3 Europe
- 7.3.1 Europe Eubiotics Revenue (2020-2031)
- 7.3.2 Europe Eubiotics Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Eubiotics Revenue (2020-2031)
- 7.4.2 Asia-Pacific Eubiotics Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Eubiotics Revenue (2020-2031)
- 7.5.2 South America, Middle East and Africa Eubiotics Revenue Share by Country: 2020 VS 2024 VS 2031
- 8 Company Profiles
- 8.1 YARA International Asa
- 8.1.1 YARA International Asa Comapny Information
- 8.1.2 YARA International Asa Business Overview
- 8.1.3 YARA International Asa Eubiotics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.1.4 YARA International Asa Eubiotics Product Portfolio
- 8.1.5 YARA International Asa Recent Developments
- 8.2 SCC Holdings Berhad
- 8.2.1 SCC Holdings Berhad Comapny Information
- 8.2.2 SCC Holdings Berhad Business Overview
- 8.2.3 SCC Holdings Berhad Eubiotics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.2.4 SCC Holdings Berhad Eubiotics Product Portfolio
- 8.2.5 SCC Holdings Berhad Recent Developments
- 8.3 Royal DSM
- 8.3.1 Royal DSM Comapny Information
- 8.3.2 Royal DSM Business Overview
- 8.3.3 Royal DSM Eubiotics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.3.4 Royal DSM Eubiotics Product Portfolio
- 8.3.5 Royal DSM Recent Developments
- 8.4 Kemin Industries
- 8.4.1 Kemin Industries Comapny Information
- 8.4.2 Kemin Industries Business Overview
- 8.4.3 Kemin Industries Eubiotics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.4.4 Kemin Industries Eubiotics Product Portfolio
- 8.4.5 Kemin Industries Recent Developments
- 8.5 DuPont
- 8.5.1 DuPont Comapny Information
- 8.5.2 DuPont Business Overview
- 8.5.3 DuPont Eubiotics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.5.4 DuPont Eubiotics Product Portfolio
- 8.5.5 DuPont Recent Developments
- 8.6 Chr. Hansen A/S
- 8.6.1 Chr. Hansen A/S Comapny Information
- 8.6.2 Chr. Hansen A/S Business Overview
- 8.6.3 Chr. Hansen A/S Eubiotics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.6.4 Chr. Hansen A/S Eubiotics Product Portfolio
- 8.6.5 Chr. Hansen A/S Recent Developments
- 8.7 Cargill Incorporated
- 8.7.1 Cargill Incorporated Comapny Information
- 8.7.2 Cargill Incorporated Business Overview
- 8.7.3 Cargill Incorporated Eubiotics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.7.4 Cargill Incorporated Eubiotics Product Portfolio
- 8.7.5 Cargill Incorporated Recent Developments
- 8.8 Beneo Group
- 8.8.1 Beneo Group Comapny Information
- 8.8.2 Beneo Group Business Overview
- 8.8.3 Beneo Group Eubiotics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.8.4 Beneo Group Eubiotics Product Portfolio
- 8.8.5 Beneo Group Recent Developments
- 8.9 Behn Meyer Group
- 8.9.1 Behn Meyer Group Comapny Information
- 8.9.2 Behn Meyer Group Business Overview
- 8.9.3 Behn Meyer Group Eubiotics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.9.4 Behn Meyer Group Eubiotics Product Portfolio
- 8.9.5 Behn Meyer Group Recent Developments
- 8.10 BASF SE
- 8.10.1 BASF SE Comapny Information
- 8.10.2 BASF SE Business Overview
- 8.10.3 BASF SE Eubiotics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.10.4 BASF SE Eubiotics Product Portfolio
- 8.10.5 BASF SE Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Eubiotics Value Chain Analysis
- 9.1.1 Eubiotics Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Eubiotics Production Mode & Process
- 9.2 Eubiotics Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Eubiotics Distributors
- 9.2.3 Eubiotics Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.